Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Kura Oncology, Inc. - Common Stock (NQ:KURA)

7.480 +0.140 (+1.91%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Kura Oncology, Inc. - Common Stock

< Previous 1 2 3 4 Next >
Evolv Technologies, Precigen, Hesai Group And Other Big Stocks Moving Higher On Friday
 
Via Benzinga
Kura (KURA) Revenue Drops 61%
Via The Motley Fool
Earnings Scheduled For August 7, 2025
 
Via Benzinga
Earnings Scheduled For May 1, 2025
 
Via Benzinga
Uncovering Potential: Kura Oncology's Earnings Preview
 
Via Benzinga
Excelerate Energy, MediaAlpha And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
 
Via Benzinga
Earnings Scheduled For February 26, 2025
 
Via Benzinga
2 Incredible Growth Stocks to Buy Hand Over Fist
These two healthcare growth stocks could have a lot more room to run. 
Via The Motley Fool
Kura Oncology: Q4 Earnings Insights
 
Via Benzinga
Here’s Why Shuttle Pharma is the Most Undervalued Biotech Stock in Our Coverage Universe
Via Stocktwits
Kura Oncology Cancer Study Hits Primary Goal, Lays Out Plans For Phase 3 Studies
Kura Oncology and Kyowa Kirin reported positive Phase 2 results for ziftomenib in AML and plan Phase 3 trials, with an NDA submission set for Q2 2025. 
Via Benzinga
These stocks are moving in today's after hours session
After the conclusion of the US market's regular session on Wednesday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
Nasdaq Edges Higher; Baidu Shares Fall After Q3 Results
 
Via Benzinga
Earnings Scheduled For February 27, 2024
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million. 
Via Benzinga
Earnings Outlook For Kura Oncology
 
Via Benzinga
Crude Oil Gains 1%; Deere Posts Better-Than-Expected Earnings
 
Via Benzinga
Dow Jumps Over 100 Points; Nvidia Posts Upbeat Earnings
 
Via Benzinga
Topics Stocks
Kura Oncology Slams The Door On Its Takeover Narrative, And Shares Collapse 26%
Instead of seeking a takeover, the company inked a deal worth up to $1.53 billion for its lead asset. 
Via Investor's Business Daily
Maximus Reports Weak Earnings, Joins Atkore, PDD Holdings And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
 
Via Benzinga
This Caterpillar Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday
 
Via Benzinga
KURA Stock Earnings: Kura Oncology Beats EPS for Q2 2024
KURA stock results show that Kura Oncology beat analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
7 ‘Death Cross’ Stocks That Could Be Contrarian Buys
Although death cross stocks sound incredibly ominous, they could be the ideal time to consider a contrarian position. 
Via InvestorPlace
KURA Stock Earnings: Kura Oncology Misses EPS for Q1 2024
KURA stock results show that Kura Oncology missed analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
MAIA Biotechnology: Undervalued With Eye-Popping Cancer Data And Partnership Potential
MAIA Biotechnology, a biotechnology company developing innovative cancer treatments, has seen its stock drift downwards for the past months. 
Via Talk Markets
Kura Makes Good On Its $150 Million Infusion And Shoots Up Another 15%
The company just released promising results for its acute myeloid leukemia treatment. 
Via Investor's Business Daily
Why UPS Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of United Parcel Service, Inc. (NYSE: UPS) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter sales results and issued FY24 sales 
Via Benzinga
Why Cancer-Drug Developer Kura Oncology Stock Is Up
Kura Oncology, Inc. shares are trading higher Tuesday after the company reported preliminary clinical data from the first 20 patients its Komet-007 Phase 1 dose-escalation trial. Kura reported that all... 
Via Benzinga
General Motors Posts Upbeat Earnings, Joins Corning, HCA Healthcare And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded slightly lower, with the Dow Jones falling around 20 points on Tuesday. 
Via Benzinga
Topics Stocks
Dow Edges Lower; US Composite PMI Rises In January
U.S. stocks traded mixed toward the end of trading, with the Dow Jones index turning lower on Wednesday. The Dow traded down 0.05% to 37,886.62 while the NASDAQ rose 0.59% to 15,517.32. The S&P 500... 
Via Benzinga
Topics Stocks
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.